Gardasil Allegedly Subjected Recipients to Autoimmune Disorders

A lawyer with an extensive history of representing clients in wrongful death and personal injury cases, Michael Lin Baum has spent nearly four decades as managing partner of Baum Hedlund Aristei & Goldman in Los Angeles, California, where he oversees all aspects of the firm, including mass tort litigation. As an attorney, Michael Lin Baum’s current legal case involves injuries caused by Merck’s Gardasil HPV vaccination.
The HPV vaccine includes a genetically modified strain of Saccharomyces cerevisiae (yeast) as an expedient. While S. cerevisiae has proven efficacy in strengthening the immune system and wound healing, past studies have also raised awareness of detrimental adverse effects (autoimmune disorders) that yeast could trigger if the immune system cannot cope with that dosage.
Autoimmune disorders occur when the immune system destroys healthy body tissues. Typically, the immune system recognizes yeast as a foreign invader and creates antibodies to fight yeast antigens (proteins). Although this mechanism is the same way the immune system fights infection, yeast may be present in the body in residual amounts and will not be considered an infection since it urges the immune system to create more antibodies and become stronger. In adverse cases, however, there might be a production of an abnormally high concentration of antibodies, causing the immune system to begin attacking healthy cells instead. These unusually high levels of S. cerevisiae antibodies have been found in patients with autoimmune diseases like rheumatoid arthritis, lupus erythematosus, and certain types of diabetes.
As a result, there’s a high chance that Gardasil is responsible for most autoimmune injuries that are rampant among patients who are recipients of the HPV vaccine– advertised as protection against the human papillomavirus. Consequently, Gardasil’s manufacturer, Merck, is facing multiple related lawsuits.